KMG Capital Partners

Circuit Clinical is an integrated research organization that has emerged from the experience of a physician engaged in clinical research within a private practice. Established in 2015, the company aims to enhance the way clinical research is conducted by emphasizing physician and participant engagement. Circuit Clinical leverages a network of over 1 million patients, utilizing direct HIPAA/FDA-compliant Electronic Medical Record reviews to identify motivated participants. The organization provides research services that facilitate access to clinical research, guiding both experienced and novice community physicians and their patients through each step of the clinical research process. Through its technology products and focus on participant and physician experience, Circuit Clinical seeks to improve research site quality and patient safety, creating a more efficient pathway for clinical research.

TriSalus Life Sciences is a biotechnology company based in Westminster, Colorado, founded in 2009. The company specializes in developing innovative precision infusion systems for the interventional radiology market, focusing on the treatment of liver and pancreatic cancers. TriSalus's flagship products include the Surefire precision infusion systems, which utilize a unique expandable tip design to deliver embolic agents precisely while minimizing damage to healthy tissue. The company also offers Pressure Enabled Drug Delivery (PEDD) systems and is developing an investigational agent, nelitolimod, aimed at enhancing immune responses in cancer therapies. Additionally, TriSalus is advancing its TriNav therapy delivery device, which incorporates SmartValve technology for improved drug delivery.

Bottlenose, Inc. is a business intelligence software company that specializes in real-time data analysis to help enterprises identify threats and opportunities. Founded in 2010, the company is headquartered in San Francisco, California, with additional offices in Los Angeles and New York City. Its flagship product, Nerve Center, is a SaaS-based solution that enables analysts and strategists to monitor both internal and external factors affecting their businesses. By utilizing advanced machine learning, data mining, and predictive analytics, Nerve Center transforms complex data streams into actionable insights. The platform is designed to detect patterns and trends across various domains, including brand reputation, consumer insights, competitive intelligence, and crisis response. Bottlenose primarily serves Fortune 100 companies, assisting them in developing data-driven strategies to enhance customer engagement and optimize business performance.

Coherus Biosciences is a biopharmaceutical company that specializes in the development, manufacture, and commercialization of biologic therapeutics, with a strong emphasis on oncology and inflammatory diseases. The company is actively engaged in research and development, focusing on process science, analytical characterization, and protein production. Coherus's portfolio includes FDA-approved products such as UDENYCA, a biosimilar of Neulasta, and it plans to launch YUSIMRY, a biosimilar of Humira, in the United States. Additionally, the company is advancing a pipeline of biosimilar candidates across areas such as immunology and ophthalmology, as well as anti-tumor necrosis factor treatments. With a commitment to building an immuno-oncology franchise, Coherus aims to leverage its diversified portfolio to generate revenue and enhance patient access to biologic therapies.

Wildflower Health, Inc. is a health engagement platform based in San Francisco, California, that provides smartphone-based health programs aimed at connecting healthcare payers with families across the United States. Founded in 2012, the company offers a maternity program called Due Date Plus, which addresses engagement challenges by assisting women in early pregnancy and facilitating connections with care managers. Additionally, Wildflower Health provides GROW, a family health program that focuses on mothers and encompasses pediatric and family health. Its platform delivers personalized health milestones based on age and gender, along with resources such as on-device messaging, appointment reminders, health risk assessments, and provider referrals. By utilizing user-centered design and technology, Wildflower Health aims to empower families to make informed healthcare decisions and support their individual health needs over time.

FitBionic is located in Boulder, Colorado, an international epicenter of health and fitness. We are dedicated to one principle: that amputees deserve whole-person care. We believe in stimulating healthy, active lifestyles, and in offering bionics that feel as comfortable, lively, and functional as their biological equivalents. Since our founding, our R&D has been funded by the National Institutes of Health, and we've demonstrated that it's possible to create high-quality, affordable prosthetic feet that may walk more safely over any terrain, reduce pain and fall risk, and particularly serve the needs of amputees with diabetes. Our first product, the FitBionic Foot, has been demonstrated to allow amputees to walk more efficiently than with carbon fiber feet, and additional early data now points to other benefits as well, including improved overall activity and fitness. Most importantly, the first amputees to use this biomechanically designed walking foot have loved it from the first steps.